Ama-immune checkpoint inhibitors ayikilasi lezidakamizwa ezilwa namasosha omzimba ukuze alwe namaseli anomdlavuza. Nokho, iziguli eziningi aziphenduli kulezi zindlela zokwelapha. Kunesigaba esisha somuthi esiqondise amaprotheni amabili abambe iqhaza ekucindezeleni amasosha omzimba ngokumelene namathumba.
Phase I of clinical trials has shown some exciting results, which were conducted in 19 patients suffering from umdlavuza with the molecule M7824. These researchers are also undertaking trials with those suffering from umdlavuza pancreatic and those infected with HPV.
There are many other trials and experiments being taken to treat and ukwelapha umdlavuza more effectively in different research institutes. This drug with a dual approach will be a boon in the ukwelashwa komdlavuza, as with a single molecule, multiple therapies are included.
